Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Study to Assess Adherence to Apalutamide in Metastatic Hormone-Sensitive Prostate Cancer Participants in France

This study aims to explore the real-world treatment adherence, persistence of apalutamide, and assess the risk of non-adherence according to the participant's profile and behavior of metastatic hormone-sensitive prostate cancer (mHSPC) participants treated with apalutamide during the first year of continued treatment.

Participants needed: 270
Trial details
Age: 18+Biological sex: MaleType: ObservationalSponsor: Janssen Cilag S.A.S.Updated: Jun 5, 2026Locations: 1
Eligibility criteria

Male (based on chromosomal composition at birth) and aged greater than or equal... [+6]

Has already received or is currently receiving apalutamide, or any other androge... [+8]

Status: Recruiting

Benefits of Individual Physical Activity Intervention on Health-related Quality of Life in Participants With Chronic Lymphocytic Leukemia

The purpose of this study is to assess the impact of an individual physical activity intervention (IPAI) on health-related quality of life (HRQoL) in participants with first line or relapsed chronic lymphocytic leukemia (CLL) initiating ibrutinib in a routine clinical practice setting. HRQoL will be measured using functional assessment of cancer therapy - general scale (FACT-G).

Participants needed: 180
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Janssen Cilag S.A.S.Updated: Jun 5, 2026Locations: 1
Eligibility criteria

Participants newly treated with ibrutinib for first line or relapsed CLL (treatm... [+4]

Pregnant participants or planning to become pregnant while enrolled in this stud... [+4]